Publicação

Comparison of muscle strength between different clinical pathologies : heart failure, familial amyloidotic polyneurophathy and fibromyolgia.

Ver documento

Detalhes bibliográficos
Resumo:Purpose: The first objective was to compare the muscle strength between two groups of heart failure patients, according with the value of ejection fraction (EF). The second was to compare the muscle strength of upper limb between three clinical pathologies: heart failure (HF), fibromyalgia (FM) and familial amyloidotic polyneuropathy (FAP). Methods: In first objective, the muscle strength of 37 patients with HF was assessed through the 30 second chair stand test and handgrip test. Patients with EF≥40% and EF<40% were placed in low risk group and moderate risk group, respectively. For the second objective, 90 and 36 patients with FAP and FM, respectively, were added to the sample of HF, and the value of handgrip test was compared among the three pathologies. Results: No differences were found in muscle strength between the two groups of HF. Comparing the muscle strength among the three pathologies, differences were found between FM and FAP, and between FM and HF. Conclusions: Muscle strength seems to be similar in patients with HF, regardless of the value of EF. Despite the three pathologies seriously affect muscle strength, it seems that individuals with HF shows a lower impairment of muscle strength compared with patients with FM.
Autores principais:Fernandes, Bruno Miguel António
Assunto:30 Second chair stand test Ejection fraction Exercise Familial amyloidotic Fribromyalgia Functional capacity Handgrip test Heart failure Muscle strength Polyneuropathy Skeletal muscle
Ano:2012
País:Portugal
Tipo de documento:dissertação de mestrado
Tipo de acesso:acesso restrito
Instituição associada:Universidade de Lisboa
Idioma:inglês
Origem:Repositório da Universidade de Lisboa
Descrição
Resumo:Purpose: The first objective was to compare the muscle strength between two groups of heart failure patients, according with the value of ejection fraction (EF). The second was to compare the muscle strength of upper limb between three clinical pathologies: heart failure (HF), fibromyalgia (FM) and familial amyloidotic polyneuropathy (FAP). Methods: In first objective, the muscle strength of 37 patients with HF was assessed through the 30 second chair stand test and handgrip test. Patients with EF≥40% and EF<40% were placed in low risk group and moderate risk group, respectively. For the second objective, 90 and 36 patients with FAP and FM, respectively, were added to the sample of HF, and the value of handgrip test was compared among the three pathologies. Results: No differences were found in muscle strength between the two groups of HF. Comparing the muscle strength among the three pathologies, differences were found between FM and FAP, and between FM and HF. Conclusions: Muscle strength seems to be similar in patients with HF, regardless of the value of EF. Despite the three pathologies seriously affect muscle strength, it seems that individuals with HF shows a lower impairment of muscle strength compared with patients with FM.